Israel’s Alpha Tau Medical (see here previously) has treated its first patient with recurrent lung cancer using its innovative Alpha DaRT® alpha-radiation cancer therapy. The WHO reports 2.5 million new lung cancer cases annually and the most cancer-related deaths. https://www.ourcrowd.com/startup-news/alpha-tau-treats-first-patient-with-recurrent-lung-cancer … Continue reading →

Scientists at Israel’s Weizmann Institute have uncovered how aging cells evade the immune system. The protein PD-L1 stops the immune system from recognizing and destroying aging (senescent / “zombie”) cells. Antibodies to PD-L1 reduced inflammation and numbers of senescent cells. … Continue reading →

Psifas is the Israeli Genome project. With a budget of NIS 250 million, it aims to create a genetic database of 100,000 Israel’s citizens. The information collected from patients of the Clalit health company, already provides information that will make … Continue reading →

The brain’s NMDA receptor (NMDAR) is known to be vital for learning and memory. Now Tel Aviv University researchers have discovered that it also maintains stable brain function during environment and physiological changes. The discovery may lead to new treatments … Continue reading →

Tel Aviv University researchers have discovered a mutation of the TMEM16F protein secretes α-synuclein to enhance the spread of Parkinson’s pathology through nerve cells in the brain. Blocking or modulating TMEM16F activity may reduce α-synuclein and cure Parkinson’s disease. https://tps.co.il/articles/researchers-identify-key-protein-in-parkinsons-disease-spread/ … Continue reading →

Researchers from Tel Aviv University and Shamir Medical Center in Beer Yaakov found that hyperbaric oxygen therapy (HBOT) can significantly alleviate PTSD symptoms, particularly for patients unresponsive to traditional therapies or medications. https://tps.co.il/articles/hyperbaric-oxygen-therapy-may-be-game-changing-ptsd-treatment-say-researchers/

Israel’s Innoventric has developed Trillium – a device to fix a leak in the tricuspid valve, one of four valves that regulate blood flow through the heart. But instead of replacing the valve, the prosthetic device is inserted into a … Continue reading →

Israel’s Pi-Cardia (see here previously) has received US-FDA approval for its ShortCut heart valve decalcification device. ShortCut is used to remove calcium from heart valves, making them more flexible, prior to heart valve replacement (e.g. TAVR or TMVR) procedures. https://www.businesswire.com/news/home/20240928442730/en/Pi-Cardia-Receives-FDA-Market-Clearance-for-ShortCut%E2%84%A2